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SummAry
Trans-cutaneous bone conduction (BC) stimulators, when coupled to the hB (BC-hB), are generally used to predict the results that could 
be achieved after bone conductive implant (BCi) surgery, and their performance is generally considered inferior to that provided by the 
definitive percutaneous system. The aim of the present study was to compare the performances between BC-hB and BCi of the same typol-
ogy, when the former’s sound processor is fitted in accordance to the individual auditory situation. Twenty-two patients selected for surgical 
application of a BCi were evaluated and the same audiological protocol was used to select the candidate and assess the final outcome. The 
BC-hB was properly fitted based on individual hearing loss and personal auditory targets, and tested as primary step of the protocol to ob-
tain the most reliable predictive value. The BAhA Divino and BP100 sound processors were applied in 12 patients with conductive/mixed 
hearing loss (Cmhl) and in 10 subjects with single sided deafness (SSD). Audiometric evaluation included the pure tone average (PTA
3
) 
threshold between 250-1000 hz; the PTA thresholds at 2000 and 4000 hz; intelligibility scores as percentage of word recognition (WrS) 
in quiet and in noise; and subjective evaluation of perceived sound quality by a visual analogue scale (VAS). Statistical evaluation with a 
student’s t test was used for assessment of efficacy of BC-hB and BCi compared with the unaided condition. Spearman’s rho coefficient 
was used to confirm the reliability of the BC-hB simulation test as a predictor of definitive outcome. The results showed that the mean PTA 
difference between BCi and BC-hB ranged from 2.54 to 8.27 decibels in the Cmhl group and from 1.27 to 3.9 decibels in the SSD group. 
Compared with the BC-hB, BCi showed a better WrS both in Cmhl (16% in quiet and 12% in noise) and in SSD (5% in quiet and a 1% 
in noise) groups. Spearman’s rho coefficient, calculated for PTA, WrS in quiet and in noise and VAS in the two aided conditions, showed 
a significant correlation between BC-hB and BCi, between PTA and VAS and between WrS in quiet and VAS. it is possible to conclude 
that the headband test, when the sound processor of the selected bone conductive implant is fitted and personalised for individual hearing 
loss and auditory targets of the candidate, may provide highly predictive data of the definitive outcome after BCi implant surgery.
key WorDS: Bone conductive implant • Headband test • Hearing loss • Pure tone audiometry • Speech audiometry • VAS
riASSunTo
Gli stimolatori transcutanei per via ossea, quando accoppiati ad un archetto o headband (HB), vengono utilizzati per predire i risultati che potran-
no essere ottenuti dopo l’applicazione chirurgica di impianti uditivi a conduzione ossea (BCI). Generalmente, la loro efficacia viene considerata 
inferiore a quella fornita dal sistema percutaneo definitivo. In questo studio si è voluta comparare l’efficacia del sistema transcutaneo accoppiato 
all’HB (BC-HB) ed adattato alla situazione audiologica individuale, con i dati post-operatori ottenuti utilizzando lo stesso processore percutaneo. 
Ventidue pazienti, selezionati per l’applicazione chirurgica di un BCI, sono stati inclusi in questo studio e sono stati sottoposti ad uno stesso pro-
tocollo audiologico, sia per la loro candidatura che per la valutazione post-operatoria. Il BC-HB è stato accuratamente adattato all’ipoacusia ed 
agli obiettivi uditivi propri per ciascun soggetto, per poter acquisire il massimo valore predittivo. Sono stati utilizzati i processori BAHA Divino 
and BP100 in 12 pazienti con ipoacusia trasmissiva/mista, ed in 10 pazienti con sordità profonda monolaterale (single sided deafness o SSD). 
La valutazione audiologica ha incluso la soglia audiometrica tonale media tra 250 e 1000 Hz (PTA
3
); quella a 2000 e 4000 Hz; la percentuale di 
intelligibilità per le parole (WRS) in quiete e nel rumore; e la valutazione soggettiva di qualità del suono percepito usando la scala analogica vi-
siva (VAS). Il coefficiente Spearman Rho è stato utilizzato per valutare l’attendibilità del BC-HB come indicatore del risultato definitivo. I risultati 
hanno dimostrato che la differenza media tonale tra sistema percutaneo e simulatore varia dai 2,54 e gli 8,27 decibel nel gruppo con ipoacusia 
trasmissiva/mista, e dall’1,27 ed i 3,9 decibel nel gruppo SSD. Rispetto al simulatore, con il sistema impiantato si è osservato una migliore WRS: 
del 16% in quiete e del 12% nel rumore nei soggetti con ipoacusia trasmissiva/mista; e del 5% in quiete e dell’1% nel rumore nel gruppo con 
SSD. Si è in questo modo evidenziata una significativa correlazione tra i dati del simulatore e quelli dell’impianto percutaneo definitivo, tra il 
PTA ed il VAS, così come tra il WRS in quiete ed il VAS. Si può quindi concludere che il test con simulatore, quando il processore sonoro utilizzato 
viene adattato e personalizzato alle necessità uditive di ciascun soggetto, può fornire dati altamente predittivi del risultato definitivo di un BCI.
PArole ChiAVe: Impianto uditivo per via ossea • Test con archetto • Ipoacusia • Audiometria tonale • Audiometria vocale • VAS
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Introduction
Bone conduction (BC) hearing provides a different 
pathway for sound transmission and represents an al-
ternative to physiologic airborne conduction  1  2. Al-
though the actual mechanisms that produce the hear-
ing sensation when sound is transmitted through bone 
have not being fully elucidated, bone conduction hear-
ing devices, such as conventional hearing aids (hA) or 
bone-conductive implants (BCi), have allowed to over-
come some limitations that an air conduction hA car-
ries in relation to, for example, post-operative sequels 
from middle ear surgery or external ear canal chronic 
diseases 3 4. in fact, in the last decades, BCi have been 
successfully applied not only to patients with conduc-
tive or mixed hearing loss of different aetiology, but 
also to those affected by single-sided sensorineural 
deafness (SSD) by reproducing a contralateral routing 
of offside signal (CroS) amplification  5. For nearly 
three decades, percutaneous BCis have been adopted 
worldwide, allowing the osseointegrated device to di-
rectly drive bone stimulation to the cochlea, bypassing 
the damping effect of the skin and subcutaneous tis-
sue. in case of small children, in whom reduced skull 
thickness is unlikely to retain the implanted screw, the 
BC sound processor is usually stabilised with a band, 
called soft-band, that provides transcutaneous stimula-
tion. likewise, a transcutaneous BC variant, coupled 
to the hB, is routinely used during the selection pro-
cess of potential candidates, since it allows not only to 
perform the audiological evaluation, but also permits 
patients to familiarise themselves and subjectively per-
ceive its possible benefit.
it is general opinion that the functional outcome of 
a transcutaneous bone-conductive system is differ-
ent from what can be achieved by an osseointegrated 
implant. The variables in play for the reduced perfor-
mance of the transcutaneous stimulation are position of 
the bone vibrator, surface contact area, skin thickness 
and frequency stimulation. in particular, when consid-
ering the frequency range of transmission of osteointe-
grated and transcutaneous BC devices, an overlapping 
sensitivity has to be expected below 500 hz since, up 
to this frequency, the interposed skin produces no at-
tenuation  6. Beyond 500  hz, contrarily, progressive 
separation of the percutaneous and transcutaneous BC 
thresholds occurs, the former being superior by approx-
imately 4 to 7 dB when the speech reception threshold 
values are considered 6.
The present study was performed to assess the clinical 
validity of carrying out the preoperative simulation test 
with hB, when the coupled sound processor has been 
customised to the patient’s hearing loss and auditory tar-
gets, as a reliable predictor of the final outcome of BCi.
Materials and methods
Twenty-two adult subjects (10 males, 12 females), implant-
ed at a university hospital implanting Center with a single 
BCi system (BAhA®, Cochlear, mölnlycke, Sweden) were 
included in this retrospective study (Table i). Thirteen sub-
jects presented with conductive-mixed hearing loss (Cm-
hl), with mean bone-conduction threshold of 36.5  dB, 
mean air-conduction threshold of 73.1 dB and mean air-
bone gap of 36.6 dB; 9 subjects were affected by single 
sided deafness (SSD), with a contralateral mild, down-
sloping sensorineural hearing loss presumably caused by 
aging (Table ii). A BP100 sound processor (SP) was used 
in 10 patients and a Divino SP in the remaining 12.
A preoperative simulation test was performed with an indi-
vidualised fitting of the two different SPs according to type 
and degree of hearing loss. in the Divino SP, volume level 
and gain at the low frequencies were manually changed 
for Cmhl patients while, in the SSD ones, the gain at low 
frequencies was down-regulated in favour of high frequen-
cies. The microphone was always set in the omnidirectional 
configuration. The BP100 SP was fully programmed using 
dedicated preset parameters for Cmhl and SSD, optimising 
the fitting software in each patient. in mixed hearing loss, 
the wide band dynamic range compression was activated. 
Automatic noise management, active feedback cancellation, 
acoustic shock protection and the dynamic output stabiliser 
were also activated in all patients. even with this SP, the mi-
crophone was set in the omnidirectional configuration.
Audiological assessment included:
• Pure tone and speech audiometry, performed inside a 
soundproof booth with headphones, for choosing the 
ear (or the first ear) to be implanted;
• Sound-field PTA, word recognition score (WRS) in 
quiet (at 65  dB hl), and WrS in noise (S/n ratio 
+10  dB) as maximum percentage of intelligibility at 
the stimulation level of 80 dB, as maximum output of 
the loudspeaker, for collecting data. For the speech in 
noise tests, babble noise and speech were delivered 
through separate channels calibrated independently, 
with a S/n ratio +10, to the loudspeakers located in the 
Cmhl group at 0° (speech) and 180° (noise), while in 
the SSD group the multi-talker babble was directed to 
the better hearing ear, and speech to the poorer one. in 
the Cmhl group, the better ear was always occluded 
during tests. The speech material consisted in three 
lists specific to the patients’ mother tongue 7.
Single values were recorded for the unaided, BC-hB and 
post-operative BCi outcomes.
All patients also underwent subjective evaluation of sound 
quality under the three different situations, using a visual 
analogue scale (VAS), with scores ranging from 0 to 10.
mean values obtained in the Cmhl and SSD groups 
with the BC-hB and the BCi compared with the unaided 
situation were used to assess the gain of the two aided 
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situations compared with the unaided one. For statistical 
analysis, a non-parametric distribution of data was used. 
Spearman’s rho correlation coefficient (> 0.80 with p val-
ue < 0.05) was used to evaluate the correlation and signifi-
cance of BC-hB values in predicting BCi performance, in 
the Cmhl and SSD groups separately and together, for 
the following variables:
• the PTA, separately, for low (250-1000 Hz) and high 
(2000-4000 hz) frequencies, since at high frequencies 
different thresholds levels were recorded in the two 
aided situations 6 13;
• the percentage of WRS in quiet;
• the maximum WRS in noise;
• VAS as sound quality.
Spearman’s rho (ρ) coefficient was also used to assess the 
correlation of the VAS with both the 2-4 khz PTA and the 
WrS in quiet, at baseline, BC-hB and BCi conditions.
The study was performed in accordance with the princi-
ples of the 1983 Declaration of helsinki.
Results
Conductive-mixed hearing loss (CMHL)
PTA
The mean PTA values in the unaided, BC-hB and BCi 
conditions are shown in Figure 1. improvement was found 
with the BC-hB and the BCi compared with the unaided 
situation. The mean gain at low-mid frequencies (250-
1000 hz) was 19.47 dB with the BC-hB and 22.01 dB 
with the BCi; at high frequencies (2000-4000 hz) it was 
14.42 dB with the BC-hB and 22.07 with the BCi. The 
BCi gain exceeded that with the BC-hB by 2.54 dB at 
low frequencies and by 8.27 dB at high frequencies.
Speech audiometry in quiet – WRS
The mean WrS values at 65  dB in quiet are shown in 
Figure 2. The WrS values improved with both the BC-
hB and BCi. When considering the BC-hB and the BCi 
compared with the unaided condition, the mean WrS 
gain was 21% with the BC-hB, and 37% with the BCi, 
with a 16% difference (Fig. 2).
Speech audiometry in noise (S/R + 10) – Maximum WRS
The mean maximum percentage of word recognition in 
noise in the three different conditions is shown in Fig-
ure 3. The percentage of intelligibility improved with both 
the BC-hB and BCi. The mean gain compared with the 
unaided condition was 12.3% with the BC-hB and 24.5% 
with BCi, with a difference of 12.2% between the two 
aided conditions (Fig. 3).
Single sided deafness 
PTA
The PTA results in all three situations are shown in Fig-
ure 1. PTA improvement was found with both the BC-hB 
and BCi at low and high frequencies. The mean gain at 
low frequencies was 3.17 dB with the BC-hB and 4.44 dB 
with the BCi; at high frequencies, the gain was 4.44 dB 
with the BC-hB and 8.33 dB with the BCi. The gain dif-
ference between the two aided modalities was 1.27 dB at 
low frequencies and 3.9 dB at high frequencies.
Speech audiometry in quiet – WRS
The mean WrS results in all three conditions are shown 
in Figure 2. The percentage of word recognition at 65 dB 
improved with both the BC-hB and BCi. The WrS gain 
was 9% with the BC-hB and 14% with the BCi; the dif-
ference between the two aided modalities was 5%.
Speech audiometry in noise (S/N + 10)
The mean maximum percentage of word recognition in 
noise in the three different conditions is shown in Fig-
ure  3. The mean gain was 1.11% with the BC-hB and 
11.11% with the BCi compared with the unaided condi-
tion. A 10% percentage difference between the two aided 
modalities was found. The mean gain was 2 dB with the 
BC-hB and 5.5 dB with BCi.
VAS of sound quality
The mean VAS values obtained under the unaided, BC-
hB and BCi conditions, in the Cmhl and SSD groups, 
are shown in Figure 4.
in the Cmhl group, a strict correlation (ρ =0.85, p < 0.001) 
between the PTA thresholds at 250-1000 hz of the BC-hB 
and BCi was found, which was also significant for all other 
parameters (Table iii). in the SSD group, the correlation be-
tween BC-hB and BCi was also very close and significant 
Table I. Demographics and clinical characteristics of subjects included in the 
study. M: male; F: female; COM: chronic otitis media; SSD: single sided deafness.
Patient Age Gender Aetiology Type of hearing loss
A.M. 53 F Bilateral COM Mixed bilateral
G.B. 52 M Right COM Mixed right
R.B. 40 F Bilateral COM Mixed bilateral
M.C. 35 M Franceschetti S. Mixed bilateral
B.C. 35 F Bilateral COM Mixed bilateral
V.E. 45 F Right COM Mixed right
A.F. 56 F Bilateral COM Mixed bilateral
C.M. 56 F Bilateral COM Mixed bilateral
A.T. 63 F Bilateral COM Mixed bilateral
A.R.2 63 F Bilateral COM Mixed bilateral
A.R.1 51 M Goldenhar S. Mixed bilateral
V.S. 51 M Bilateral COM Mixed bilateral
L.T. 55 F Bilateral COM Mixed bilateral
C.T. 57 F Sudden hearing loss SSD
S.A. 60 M Sudden hearing loss SSD
S.A. 64 F Ear surgery SSD
R.F. 51 M Ear surgery SSD
E.M. 66 F Ear surgery SSD
DBL 57 M Ear surgery SSD
D.C. 74 F Sudden hearing loss SSD
G.F. 67 M Ear surgery SSD
O.A. 60 F Sudden hearing loss SSD
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for all parameters, except for PTA values at 250-1000 hz. 
When considering the patients together, strong correlation 
was found for the entire PTA range, which was significant 
for all parameters considered (Table iV).
in the Cmhl, a high and significant correlation was 
found between the WrS in quiet and VAS in the unaided 
(ρ = 1.00; p < 0.001), BC-hB (ρ =0.99; p < 0.001) and 
BCi (ρ = 0.99; p < 0.001) conditions. A significant corre-
lation was also found between PTA 2-4 khz and the VAS 
in the unaided (p= 0.010), BC-hB (p= 0.004) and BCi 
(p < 0.001) conditions.
in SSD, a high and significant correlation was found be-
tween the WrS in quiet and the VAS in the unaided (ρ = 
1,00; p < 0.001), BC-hB (ρ =1.00; p < 0.001) and BCi (ρ = 
0.87; p < 0.003) conditions. no correlation was found be-
tween the VAS and PTA 2-4 khz in the unaided (p > 0.05), 
BC-hB (p = 0.05) or BCi (p > 0.05) conditions.
Discussion
The differences between the transcutaneous and percutane-
ous modality of sound conduction of bone generally influ-
ence the mean auditory gain, even when a single frequency 
range is taken into consideration. At high frequencies, for 
instance, percutaneous BCi usually provides better gain 
than a transcutaneous system 8. in clinical practice, a pre-
operative trial period and audiometric tests carried out with 
the transcutaneous simulation system, such as the headband 
(hB), allow the patient to get acquainted with the sound 
delivered by the device, and also help the audiologist and 
surgeon to select the right candidate and anticipate the de-
finitive post-operative result. Pre-operative hB tests enable 
recording data with a transcutaneous mode of stimulation, 
and to compare them at a later stage with those obtained via 
the definitive BCi. Similarly to all hA-related tests, even 
in this situation audiometric tests are performed in sound 
fields with variables related to intrinsic (type and severity 
of hearing loss, uni- or bilateral hearing loss) and extrinsic 
factors (type and level of stimulation, loudspeaker position 
in the azimuth). generally, in spite of striking methodologi-
cal differences, few information is usually available in the 
literature that describes the specific setting of the simula-
tion device, which is instead analysed with fixed stimulation 
parameters, such as delivering the maximum volume with-
out balancing the frequency gain in relation to the patients’ 
hearing loss and listening need. one may assume that this 
latter adjustment is meant to compensate for the inferior ef-
ficacy of the transcutaneous bone stimulator compared with 
the percutaneous one. Furthermore, the information col-
lected by simulation tests should be different in individuals 
affected by Cmhl from those with SSD due to the different 
problems associated with the two hearing conditions, such 
as for instance loss of binaural hearing that is usually tar-
geted only in SSD. The literature in this regard has mainly 
focused on Cmhl, because after more than 30 years of ap-
plication of a BCi in this form of hearing impairment, the 
major target has uniquely been PTA gain 9-11. A recent study 
compared the pre-operative transcutaneous and postopera-
tive percutaneous conditions, reporting differences in the 
hearing threshold (5-20 dB for the range 1-4 khz and 6 dB 
for that 0.5-1 khz) as well as in speech recognition thresh-
olds (SrT improvement of 4-7 dB) 12. other investigators 
have found that the predictive value at low-frequency was 
more reliable than at high frequencies, with a hearing gain 
ranging from 1 to 18 dB 13. Snapp et al. 14 commented on the 
low sensitivity of common audiological tests for predicting 
and monitoring BCi outcomes in SSD patients, stressing 
that the tests with speech recognition in noise should play a 
major role for appropriate assessment.
At our department, all patients candidate for a BCi, being 
affected by either conductive, mixed or profound unilateral 
sensorineural hearing loss (SSD), routinely undergo a pre-
operative trial wearing a hB coupled to the same sound pro-
cessor that has been chosen to be coupled to the implanted 
Table II. Pre-operative audiometric data of subjects with mixed hearing loss, as bone-conduction and air-conduction threshold levels. PTA: pure tone audiometry.
Bone conduction thresholds Air conduction thresholds
Patient 250 500 1000 2000 4000 250 500 1000 2000 4000
A.M. 5 15 15 50 35 70 60 50 60 55
G.B. 35 50 55 60 60 105 95 85 90 115
R.B. 10 20 35 30 25 55 60 55 65 60
M.C. 5 25 35 45 40 65 60 65 65 75
B.C. 5 15 20 35 30 45 45 50 60 35
V.E. 40 45 45 65 75 105 100 110 105 110
A.F. 5 20 35 45 40 45 55 65 65 80
C.M. 20 35 40 60 70 85 90 70 90 100
A.T. 20 25 20 25 35 65 70 60 50 110
A.R.2 15 35 40 55 45 80 70 75 65 75
A.R.1 10 25 40 55 50 60 85 90 100 100
V.S. 15 40 55 65 75 55 60 80 65 95
L.T. 50 40 35 55 50 50 60 55 70 90
S. Monini et al.
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Fig. 4. a)  Mean visual analogue scale (VAS) score for con-
ductive-mixed hearing loss (CMHl) subjects in the unaided, 
headband and bone-conductive implant (BCi) conditions. b) 
Mean VAS score for single-sided deafness (SSD) subjects in 
the unaided, headband and BCi conditions.
Fig. 3. a)  Maximum percentage of word recognition sco-
re (WrS) in noise, at stimulation level of maximum WrS in 
quiet, in conductive-mixed hearing loss (CMHl) subjects, in 
the unaided, headband and bone-conductive implant (BCi) 
conditions. b)  Maximum percentage of WrS in noise, at 
stimulation level of maximum WrS in quiet, in single-sided 
deafness (SSD) subjects, in the unaided, headband and BCi 
conditions.
Fig. 2. a) percentage of word recognition score (WrS) at 65 dB 
Hl in quiet, in conductive-mixed hearing loss (CMHl) subjects, 
in the unaided, headband and bone-conductive implant (BCi) 
conditions. b) percentage of WrS at 65 dB Hl in quiet, in sin-
gle-sided deafness (SSD) subjects, in the unaided, headband 
and BCi conditions.
Fig. 1. a) pure tone average (ptA) in conductive-mixed he-
aring loss (CMHl) subjects in the unaided, headband and 
bone-conductive implant (BCi) conditions. b)  pure tone 
average (ptA) in single-sided deafness (SSD) subjects in 
the unaided, headband and bone-conductive implant (BCi) 
conditions. 
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fixture. The specific sound processor is individually fitted, 
selecting the parameters that would mostly be beneficial 
for the individual patient. in the present study, two types of 
sound processors of the same manufacturer were used: the 
BP100 and the Divino. For the BP100 SP, the fitting param-
eters set by default for conductive-mixed hearing loss and 
SSD were modified on the basis of the patient’s listening 
characteristics; for the Divino SP, the volume at the low fre-
quencies was manually regulated depending on the type of 
hearing loss: in SSD, the gain at low frequencies was de-
creased to allow better speech perception, especially in noisy 
environments, while in Cmhl, low frequency amplification 
was only finalised to improve the signal to noise ratio. Due 
to the limitation of the available devices, which do not allow 
a home-trial period, the potential candidate was left with the 
BC-hB for a few hours in different listening environments, 
before performing a series of audiological tests that have 
always included the measurement of verbal perception, in 
quiet and noise, as well as a questionnaire on the quality of 
the perceived sound in the different listening situations.
The present study has taken into consideration hearing 
function assessed both with the BC-hB and with the acti-
vated BCi, in terms of:
• hearing threshold as PTA (250-4000 hertz);
• percentage of WrS at 65 dB in quiet;
• maximum percentage of WrS in noise (S/n +10, fixing 
the stimulation loudness at 80 dB, corresponding to the 
maximum output of the loudspeaker in sound-field);
• quality of perceived sound with VAS compared with 
the unaided condition, and the statistical difference of 
the same parameters between the simulation pre-oper-
ative effects and definitive post-operative outcome.
The effect of the BCi, in the simulation and definitive 
configurations, was significantly better than in the unaid-
ed condition for all the qualitative and quantitative param-
eters. Apart from this easily predictable result, the major 
target of this study was to assess how close the two aided 
conditions would perform, so as to highlight the predic-
tive role of the BC-hB.
in conductive and mixed hearing loss, a mean intra-individ-
ual improvement after BCi was found for the PTA between 
250 and 4000  hz, for word discrimination in quiet and 
noise, and for the quality of sound. The PTA differences 
between the BCi and the BC-hB were minimal (around 
2.5 dB for low frequencies and 8 dB for high frequencies), 
while the speech performance with the BCi was better than 
with the BC-hB (16% in quiet and 12% in noise).
in the SSD group, the performance of the BCi was superi-
or to that of the BC-hB in all parameters considered. The 
mean PTA gain with the BCi, compared with the BC-hB 
condition, was minimal (around 1 dB) for low frequencies 
and up to only 4 dB for high frequencies. When testing 
speech discrimination, a better percentage of intelligibil-
ity was found with the BCi than with the BC-hB, of about 
5% in quiet and 10% in noise. The mean VAS values in 
the Cmhl and SSD groups, taken together, showed that 
the definitive BCi provided a clearer and better sound 
than both the unaided and the BC-hB condition.
The prediction of the BCi effect derived from the correla-
tion between the intra-individual changes of the variables 
in the two aided situations was extremely significant in the 
Cmhl group for low-middle frequencies, and to a lesser 
degree, but still significant, for the other parameters; in the 
SSD group, however, the correlation for low frequencies 
was poor. This latter finding is related to the fitting char-
acteristics for the SSD situation and to the minimal gain 
deliberately received at low frequencies to privilege high 
frequency gain, while trying to optimise some of the bin-
aural function features. Considering the patients together 
(Cmhl + SSD), close correlation was found for the entire 
PTA range, which was significant for all parameters.
The correlation between VAS and the other variables re-
vealed differences between the Cmhl and SSD groups in 
the three different situations. in Cmhl, in all situations, 
a close and significant correlation was found between the 
good perceived quality of sound in terms of clearness and 
openness and speech perception in quiet. When consider-
ing the correlation between VAS and 2000-4000 hz PTA, 
Table IV. Correlation level (Spearman’s rho) and significance (p) of the 
intra-individual changes in variables between the BC-HB and the BCI, in the 
entire study group. PTA: pure tone average; WRS: word recognition score.
Correlation between the intra-individual changes after the BC-HB 
and the BCI in all subjects
Variable Spearman’s Rho p value
PTA 250-500-1000 hertz (dB) 0.85 < 0.001
PTA 2000-4000 hertz (dB) 0.83 > 0.001
WRS in quiet (%) 0.61 0.003
WRS in noise (%) 0.76 < 0.001
Table III. Correlation level (Spearman’s rho) and significance (p) of the 
intra-individual changes in variables between the BC-HB and the BCI, for 
conductive-mixed hearing loss (CMHL, n = 13) and single-sided deafness 
(SSD, n = 9) subjects. PTA: Pure tone average; WRS: word recognition score.
Predictive Index of pre-operative BC-HB for the BCI outcome
Variable Spearman’s Rho p value
CMHL (n = 13)
Sound quality (VAS) 0.68 0.011
PTA 250-500-1000 Hertz (dB) 0.85 < 0.001
PTA 2-4 KHz (dB) 0.68 0.011
WRS in quiet 0.69 0.010
WRS in noise (%) 0.73 0.005
SSD (n = 9)
Sound quality (VAS) 0.90 0.001
PTA 250-500-1000 Hertz (dB) 0.56 0.119
PTA 2-4 KHz (dB) 0.88 0.002
WRS in quiet 0.92 0.001
WRS in noise (%) 0.87 0.002
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it was shown to be significant in all auditory situations, 
but correlated highly only with the BCi. The correlation 
between sound quality, sound-field speech perception and 
high-frequency gain with a BCi has already been recently 
shown 13. in the SSD group, in contrast, a high and sig-
nificant correlation of VAS was shown only with the WrS 
percentage in quiet, in all three situations. This finding 
means that in the SSD, verbal and speech perception are 
related with directional hearing and follow two separate 
analytic processing cues, the first simply auditory and the 
second linked to multi-sensorial inputs.
Apart from the efficacy of the BCi compared to the un-
aided situation in the Cmhl and SSD groups, the present 
study showed that the use of a personalised, well-fitted 
SP coupled to a hB in pre-operative simulation tests is 
reliable in predicting the final BCi advantages not only 
for hearing improvement, but also for speech perception 
in noise and quality of listening. The accuracy of the out-
come prediction is motivated by the fact that, contrary to 
previous reports, the differences between PTA and WrS 
in the two aided conditions were minimal 14. This assump-
tion is also confirmed by the strong and significant corre-
lation with all variables taken into consideration, as well 
as in the VAS when comparing hearing function with the 
BC-hB with that of the definitive implant.
it is possible to comment that the main reason for pre-
operatively assessing a BCi candidate with a transcuta-
neous hB-coupled processor is to allow the subject to 
experience the actual advantages of bone conduction 
stimulation carried out using a modality that is mostly 
reproduced by the definitive BCi. in our opinion, these 
simulation tests can be reliable only if the drawback of 
the skin attenuation related to the transcutaneous condi-
tion is partially compensated by fitting the SP simulator 
on the basis of individual hearing loss, as well as the 
needs and individual targets of each candidate, rather 
than using a preset configuration.
Conclusions
The present study shows that when using pre-operative 
audiological assessment with a BC-hB simulator as a 
predictor of a BCi outcome, the simulation device should 
be fitted with the same modality used for the definitive 
BCi, while assessing audiological performances not only 
as PTA auditory gain, but mostly as speech perception in 
noise and improvement of the quality of perceived sound. 
The outcome of such an evaluation may allow patients, 
audiologists and surgeons to obtain an accurate estimate 
of the final outcome after BCi application.
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